Oncothyreon And Celldex Therapeutics Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 and Varlilumab

By: via Benzinga
Oncothyreon Inc. (Nasdaq: ONTY) and Celldex Therapeutics, Inc., (Nasdaq: CLDX) today announced that they have initiated a combined ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.